Leukemia (peds): Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
==Background== | ==Background== | ||
*Most common cancer in children (33% of all malignancies) | *Most common cancer in children (33% of all malignancies) | ||
*Most without cause but increased incidence with paternal age, maternal fetal loss, higher birthweight, familial clusters, and some genetic syndromes (Down syndrome) | |||
===[[acute lymphocytic leukemia|ALL]]=== | ===[[acute lymphocytic leukemia|ALL]]=== | ||
*3/4 of pediatric leukemias | *3/4 of pediatric leukemias | ||
*5-year survival 75%-80% | *5-year survival 75%-80% | ||
*Peak incidence | *Peak incidence 2-5yr old | ||
*Usually B lineage | |||
===[[AML]]=== | ===[[AML]]=== | ||
| Line 14: | Line 16: | ||
==Clinical Features== | ==Clinical Features== | ||
===Presentation=== | |||
*Hepatomegaly and/or splenomegaly with weight loss, abdominal dissension or abdominal pain | |||
*Lymphadenopathy | |||
*Fever | |||
*Bleeding (petechiae, purpura), low platelet count, anemia | |||
*MSK pain, limp, refusal to bear weight | |||
*Larger anterior mediastinal mass could cause SVC syndrome | |||
===Bone marrow infiltration and failure=== | ===Bone marrow infiltration and failure=== | ||
*Pallor, [[fatigue]], easy bleeding, [[fever]], infection | *Pallor, [[fatigue]], easy bleeding, [[fever]], infection | ||
| Line 38: | Line 49: | ||
**[[Stem cell transplant complications]] | **[[Stem cell transplant complications]] | ||
**Catheter-related complications | **Catheter-related complications | ||
**Tunnel infection | ***Tunnel infection | ||
***Exit site infection | ***Exit site infection | ||
***CVC obstruction (intraluminal or catheter tip thrombosis) | ***CVC obstruction (intraluminal or catheter tip thrombosis) | ||
| Line 48: | Line 59: | ||
*[[Aplastic anemia]] | *[[Aplastic anemia]] | ||
*Iron deficiency [[anemia]] | *Iron deficiency [[anemia]] | ||
*Viral infection ([[EBV]], [[CMV]], [[parvovirus B19|Parvo]]) | *Viral infection ([[EBV]], [[CMV]], [[parvovirus B19|Parvo]]), [[HIV]] | ||
*Immune [[thrombocytopenia]] | *Immune [[thrombocytopenia]] | ||
*Rheumatologic diseases | *Rheumatologic diseases | ||
| Line 55: | Line 66: | ||
*CBC with manual differential | *CBC with manual differential | ||
**If suggestive of leukemia also order: | **If suggestive of leukemia also order: | ||
***Review of peripheral smear | |||
***Chemistry, Ca, Phos, Mg, Uric acid, [[LFTs]], LDH, coags, T+S, UCG (if applicable) | ***Chemistry, Ca, Phos, Mg, Uric acid, [[LFTs]], LDH, coags, T+S, UCG (if applicable) | ||
***Viral titers cytomegalovirus, EBV, HIV, HBV, varicella zoster | ***Viral titers cytomegalovirus, EBV, HIV, HBV, varicella zoster | ||
***[[CXR]] | ***[[CXR]]to look for mediastinal mass | ||
***Consider [[DIC]] labs | ***Consider [[DIC]] labs, coag studies | ||
==Management== | ==Management== | ||
| Line 85: | Line 97: | ||
==Disposition== | ==Disposition== | ||
* | *Admit for further workup including bone marrow biopsy and LP | ||
==See Also== | ==See Also== | ||
Revision as of 17:26, 15 April 2022
This page is for pediatric patients. For adult patients, see: leukemia
Background
- Most common cancer in children (33% of all malignancies)
- Most without cause but increased incidence with paternal age, maternal fetal loss, higher birthweight, familial clusters, and some genetic syndromes (Down syndrome)
ALL
- 3/4 of pediatric leukemias
- 5-year survival 75%-80%
- Peak incidence 2-5yr old
- Usually B lineage
AML
- 1/5 of pediatric leukemias
- Worse prognosis
- More complications (more intense chemo treatment required)
Clinical Features
Presentation
- Hepatomegaly and/or splenomegaly with weight loss, abdominal dissension or abdominal pain
- Lymphadenopathy
- Fever
- Bleeding (petechiae, purpura), low platelet count, anemia
- MSK pain, limp, refusal to bear weight
- Larger anterior mediastinal mass could cause SVC syndrome
Bone marrow infiltration and failure
- Pallor, fatigue, easy bleeding, fever, infection
- Bone pain/arthralgia
- Hepatomegaly or splenomegaly
Hyperleukocytosis
- Clinically significant when WBC > 200K in AML, >300K in ALL
- Cerebral circulation: headache, altered mental status, visual disturbances, seizure, CVA
- Pulmonary circulation: shortness of breath, hypoxemia
Complications
- Tumor lysis syndrome
- Neutropenic fever, Sepsis, overall increased risk of infection
- Leukostasis and hyperleukocytosis
- Hyperviscosity syndrome
- Thromboembolism
- Treatment-related complications
- Chemotherapy-induced nausea and vomiting
- Cytokine release syndrome
- Chemotherapeutic drug extravasation
- Differentiation syndrome (retinoic acid syndrome) in APML
- Stem cell transplant complications
- Catheter-related complications
- Tunnel infection
- Exit site infection
- CVC obstruction (intraluminal or catheter tip thrombosis)
- Catheter-related venous thrombosis
- Fracture of catheter lumen
Differential Diagnosis
Leukemias will often involve >1 cell line; other conditions restricted to single line
- Aplastic anemia
- Iron deficiency anemia
- Viral infection (EBV, CMV, Parvo), HIV
- Immune thrombocytopenia
- Rheumatologic diseases
Evaluation[1]
- CBC with manual differential
Management
Transfusion
- Options
- Irradiated: for very immunosuppressed (to prevent graft vs host)
- Leukocyte-reduced: for patients likely to receive multiple RBC or platelets in future
- CMV seronegative: for <1yr old, if might need bone marrow transplant in future
- Anemia
- 10 cc/kg of pRBCs raises hemoglobin by 3 gm/dL
- Raise hemoglobin to >8
- Thrombocytopenia
- 0.1 unit/kg platelets results in 30-50K increase in platelet count
- Risk of spontaneous ICH is extremely low until platelets <5K
- Transfuse if:
- Asymptomatic with platelets <10K
- Invasive procedures require platelets >50K
Leukostasis and Hyperleukocytosis
- Aggressive IV hydration
- Urinary alkalinization (pH 7-7.5)
- Allopurinol (for Tumor Lysis Syndrome (TLS))
- Avoid diuretics and pRBC transfusion (platelets ok)
- Give platelets if <20K
- Leukapheresis
Disposition
- Admit for further workup including bone marrow biopsy and LP
See Also
References
- ↑ Horton TM and Steuber CP. Overview of the presentation and diagnosis of acute lymphoblastic leukemia in children and adolescents. UpToDate.
